Prestwick Pharmaceuticals
About Prestwick Pharmaceuticals
Prestwick Pharmaceuticals is a company founded in 2002 was acquired by Biovail in September 2008.. Prestwick Pharmaceuticals has raised $103.79 million across 6 funding rounds from investors including Warburg Pincus, FirstMark and Atlas Venture. Prestwick Pharmaceuticals offers products and services including Antibodies, Assay Kits, ELISA Kits, and PCR Kits.
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$103.79 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series C
Aug 27, 2007
-
Investors
Warburg Pincus
& 7 more
-
Employee Count
Employee Count
-
Acquired by
Biovail
(Sep 17, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prestwick Pharmaceuticals
Prestwick Pharmaceuticals offers a comprehensive portfolio of products and services, including Antibodies, Assay Kits, ELISA Kits, and PCR Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for detecting specific proteins in research and diagnostics.
Kits for testing biological samples in various assays.
Tools for enzyme-linked immunosorbent assays in disease detection.
Kits for polymerase chain reaction in DNA amplification.
Funding Insights of Prestwick Pharmaceuticals
Prestwick Pharmaceuticals has successfully raised a total of $103.79M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $20.0M
-
First Round
First Round
(19 Jun 2003)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2007 | Amount | Series C - Prestwick Pharmaceuticals | Valuation |
investors |
|
| Aug, 2007 | Amount | Debt – Convertible - Prestwick Pharmaceuticals | Valuation |
investors |
|
| Aug, 2006 | Amount | Series C - Prestwick Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prestwick Pharmaceuticals
Prestwick Pharmaceuticals has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Warburg Pincus, FirstMark and Atlas Venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is invested in tech startups across sectors.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are focused on US companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prestwick Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prestwick Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prestwick Pharmaceuticals Comparisons
Competitors of Prestwick Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Prestwick Pharmaceuticals
Frequently Asked Questions about Prestwick Pharmaceuticals
When was Prestwick Pharmaceuticals founded?
Prestwick Pharmaceuticals was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Is Prestwick Pharmaceuticals a funded company?
Prestwick Pharmaceuticals is a funded company, having raised a total of $103.79M across 6 funding rounds to date. The company's 1st funding round was a Series C of $31.79M, raised on Jun 19, 2003.
What does Prestwick Pharmaceuticals do?
Prestwick Pharmaceuticals was founded in 2002 as a specialty pharmaceutical company focused on the development and commercialization of small molecule drugs targeting chronic central nervous system diseases. Operations included early-stage products such as Lisuride for Parkinsons disease and D-Serine for schizophrenia. An exclusive U.S. commercialization agreement for Xenazine in Huntingtons disease was established with Ovation Pharmaceuticals. The company was acquired by Biovail Corp. in September 2008.
What products or services does Prestwick Pharmaceuticals offer?
Prestwick Pharmaceuticals offers Antibodies, Assay Kits, ELISA Kits, and PCR Kits.
Who are Prestwick Pharmaceuticals's investors?
Prestwick Pharmaceuticals has 8 investors. Key investors include Warburg Pincus, FirstMark, Atlas Venture, Biovail, and Scale Venture Partners.